 | • レポートコード：PMR2201A042 • 出版社/出版日：Persistence Market Research / 2021年10月20日 • レポート形態：英文、PDF、158ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査レポートは、世界の経口高分子製剤市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、市場背景、新型コロナウイルス感染症の危機分析、主要成功要因、市場需要分析/予測、疾患別（炎症性腸疾患、糖尿病、その他）分析、エンドユーザー別（製薬企業、学術・研究機関）分析、地域別分析、主要国分析、市場構造分析、競争分析、仮定、調査手法などを掲載しています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・市場背景 ・新型コロナウイルス感染症の危機分析 ・主要成功要因 ・市場需要分析/予測 ・世界の経口高分子製剤市場規模：疾患別（炎症性腸疾患、糖尿病、その他） ・世界の経口高分子製剤市場規模：エンドユーザー別（製薬企業、学術・研究機関） ・世界の経口高分子製剤市場規模：地域別 ・主要国分析 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Oral Macromolecular Formulation Market – Scope of Report
The latest publication by Persistence Market Research on the global oral macromolecular formulation market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market.
The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for oral macromolecular formulation products and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the oral macromolecular formulation market.
The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the oral macromolecular formulation market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the oral macromolecular formulation market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the oral macromolecular formulation market offers information divided into three important segments – indication, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Indication
Inflammatory Bowel Disorder
Crohn’s Disease
Ulcerative Colitis
Diabetes
Others
End User
Biopharmaceutical Companies
Academic and Research Institutes
Region
North America
Europe
Asia Pacific
Others
Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for oral macromolecular formulations over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the market avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the oral macromolecular formulation market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the oral macromolecular formulation market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion & Exclusion
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation / Development Trends
3.3. Clinical pipeline assessment
4. Market Background
4.1. Macro-Economic Factors
4.1.1. GDP Growth Outlook
4.1.2. Biopharmaceutical Outlook
4.1.3. Global R&D Spending Outlook
4.2. Forecast Factors – Relevance & Impact
4.2.1. Rising number of biopharmaceutical companies
4.2.2. Increase in R&D spending
4.2.3. Advancement in Technology
4.2.4. Increasing prevalence of diseases
4.2.5. Increasing clinical trials
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
5. COVID19 Crisis Analysis
5.1. Current Economic Projection as compared to 2008 financial analysis
5.2. COVID19 and Impact Analysis
5.2.1. Revenue by Indication
5.2.2. Revenue by End User
5.2.3. Revenue by Country
5.3. 2020 Market Scenario
6. Key Success Factors
6.1. Disease Epidemiology
7. Global Oral Macromolecular Formulation Market Value Analysis 2016-2020 and Forecast, 2021-2031
7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Oral Macromolecular Formulation Market Analysis 2016-2020 and Forecast 2021-2031, by Indication
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis by Indication, 2016-2020
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Indication, 2021-2031
8.3.1. Inflammatory Bowel Disorder
8.3.1.1. Crohn’s Disease
8.3.1.2. Ulcerative Colitis
8.3.2. Diabetes
8.3.3. Others
8.4. Market Attractiveness Analysis by Indication
9. Global Oral Macromolecular Formulation Market Analysis 2016-2020 and Forecast 2021-2031, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End User, 2016-2020
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2021-2031
9.3.1. Biopharmaceutical Companies
9.3.2. Academic and Research Institutes
9.4. Market Attractiveness Analysis by End User
10. Global Oral Macromolecular Formulation Market Analysis 2016-2020 and Forecast 2021-2031, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2020
10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031
10.3.1. North America
10.3.2. Europe
10.3.3. Asia Pacific
10.3.4. Others
10.4. Market Attractiveness Analysis By Region
11. North America Oral Macromolecular Formulation Market Analysis 2016-2020 and Forecast 2021-2031
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Indication
11.3.3. By End User
11.4. Market Attractiveness Analysis
11.5. Key Market Participants – Intensity Mapping
11.6. Drivers and Restraints – Impact Analysis
12. Europe Oral Macromolecular Formulation Market Analysis 2016-2020 and Forecast 2021-2031
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. Italy
12.3.1.3. France
12.3.1.4. U.K.
12.3.1.5. Russia
12.3.1.6. Rest of Europe
12.3.2. By Indication
12.3.3. By End User
12.4. Market Attractiveness Analysis
12.5. Key Market Participants – Intensity Mapping
12.6. Drivers and Restraints – Impact Analysis
13. Asia Pacific Oral Macromolecular Formulation Market Analysis 2016-2020 and Forecast 2021-2031
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
13.3.1. By Country
13.3.1.1. China
13.3.1.2. Japan
13.3.1.3. India
13.3.2. By Indication
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants – Intensity Mapping
13.6. Drivers and Restraints – Impact Analysis
14. Others Oral Macromolecular Formulation Market Analysis 2016-2020 and Forecast 2021-2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
14.3.1. By Indication
14.3.2. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants – Intensity Mapping
14.6. Drivers and Restraints – Impact Analysis
15. Key Countries Oral Macromolecular Formulation Market Analysis 2021 & 2031
15.1. Introduction
15.1.1. Market Value Proportion Analysis, By Key Countries
15.1.2. Global Vs. Country Growth Comparison
15.2. U.S. Oral Macromolecular Formulation Market Analysis
15.2.1. By Indication
15.2.2. By End User
15.3. Canada Oral Macromolecular Formulation Market Analysis
15.3.1. By Product Type
15.3.2. By Indication
15.3.3. By End User
15.4. U.K. Oral Macromolecular Formulation Market Analysis
15.4.1. By Indication
15.4.2. By End User
15.5. Germany Oral Macromolecular Formulation Market Analysis
15.5.1. By Indication
15.5.2. By End User
15.6. France Oral Macromolecular Formulation Market Analysis
15.6.1. By Indication
15.6.2. By End User
15.7. Italy Oral Macromolecular Formulation Market Analysis
15.7.1. By Indication
15.7.2. By End User
15.8. Russia Oral Macromolecular Formulation Market Analysis
15.8.1. By Indication
15.8.2. By End User
15.9. China Oral Macromolecular Formulation Market Analysis
15.9.1. By Indication
15.9.2. By End User
15.10. Japan Oral Macromolecular Formulation Market Analysis
15.10.1. By Indication
15.10.2. By End User
15.11. India Oral Macromolecular Formulation Market Analysis
15.11.1. By Indication
15.11.2. By End User
16. Market Structure Analysis
16.1. Market Analysis by Tier of Companies
16.2. Market Concentration
16.3. Market Share Analysis of Top Players
16.4. Market Presence Analysis
16.4.1. By Regional Foot Print of Players
16.4.2. Product Foot Print by Players
16.4.3. Channel Foot Print by Players
17. Competition Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Competition Deep Dive
17.3.1. Catalent Inc.
17.3.1.1. Overview
17.3.1.2. Product Portfolio
17.3.1.3. Analyst Commentary
17.3.1.4. Key Financials
17.3.1.5. Recent Developments
17.3.1.6. Sales Footprint
17.3.1.7. Strategy Overview
17.3.1.7.1. Marketing Strategy
17.3.1.7.2. Product Strategy
17.3.1.7.3. Channel Strategy
17.3.2. Diabetology Ltd
17.3.2.1. Overview
17.3.2.2. Product Portfolio
17.3.2.3. Analyst Commentary
17.3.2.4. Key Financials
17.3.2.5. Recent Developments
17.3.2.6. Sales Footprint
17.3.2.7. Strategy Overview
17.3.2.7.1. Marketing Strategy
17.3.2.7.2. Product Strategy
17.3.2.7.3. Channel Strategy
17.3.3. UPM Pharmaceuticals
17.3.3.1. Overview
17.3.3.2. Product Portfolio
17.3.3.3. Analyst Commentary
17.3.3.4. Key Financials
17.3.3.5. Recent Developments
17.3.3.6. Sales Footprint
17.3.3.7. Strategy Overview
17.3.3.7.1. Marketing Strategy
17.3.3.7.2. Product Strategy
17.3.3.7.3. Channel Strategy
18. Assumptions and Acronyms Used
19. Research Methodology
Table 1: Global Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By IndicationTable 2: Global Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 3: Global Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 4: North America Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 5: North America Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 6: North America Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 7: Europe Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 8: Europe Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 9: Europe Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 10: Asia Pacific Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 11: Asia Pacific Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 12: Asia Pacific Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 13: Others Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 14: Others Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User